Literature DB >> 33684942

Cryo-EM structures of human coagulation factors V and Va.

Eliza A Ruben1, Michael J Rau2, James A J Fitzpatrick2,3,4,5, Enrico Di Cera1.   

Abstract

Coagulation factor V (fV) is the precursor of fVa, which, together with fXa, Ca2+, and phospholipids, defines the prothrombinase complex and activates prothrombin in the penultimate step of the coagulation cascade. We solved the cryogenic electron microscopy (cryo-EM) structures of human fV and fVa at atomic (3.3 Å) and near-atomic (4.4 Å) resolution, respectively. The structure of fV reveals the entire A1-A2-B-A3-C1-C2 assembly, but with a surprisingly disordered B domain. The C1 and C2 domains provide a platform for interaction with phospholipid membranes and support the A1 and A3 domains, with the A2 domain sitting on top of them. The B domain is highly dynamic and visible only for short segments connecting to the A2 and A3 domains. The A2 domain reveals all sites of proteolytic processing by thrombin and activated protein C, a partially buried epitope for binding fXa, and fully exposed epitopes for binding activated protein C and prothrombin. Removal of the B domain and activation to fVa exposes the sites of cleavage by activated protein C at R306 and R506 and produces increased disorder in the A1-A2-A3-C1-C2 assembly, especially in the C-terminal acidic portion of the A2 domain that is responsible for prothrombin binding. Ordering of this region and full exposure of the fXa epitope emerge as necessary steps in the assembly of the prothrombin-prothrombinase complex. These structures offer molecular context for the function of fV and fVa and pioneer the analysis of coagulation factors by cryo-EM.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33684942      PMCID: PMC8176766          DOI: 10.1182/blood.2021010684

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  64 in total

1.  The factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of factor V using alanine scanning mutagenesis.

Authors:  Mahasen Saleh; Weimin Peng; Mary Ann Quinn-Allen; Sandra Macedo-Ribeiro; Pablo Fuentes-Prior; Wolfram Bode; William H Kane
Journal:  Thromb Haemost       Date:  2004-01       Impact factor: 5.249

Review 2.  Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.

Authors:  Björn Dahlbäck
Journal:  Int J Lab Hematol       Date:  2016-05-09       Impact factor: 2.877

3.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy.

Authors:  Shawn Q Zheng; Eugene Palovcak; Jean-Paul Armache; Kliment A Verba; Yifan Cheng; David A Agard
Journal:  Nat Methods       Date:  2017-02-27       Impact factor: 28.547

Review 4.  A new look at blood coagulation factor V.

Authors:  Rodney M Camire
Journal:  Curr Opin Hematol       Date:  2011-09       Impact factor: 3.284

5.  A control switch for prothrombinase: characterization of a hirudin-like pentapeptide from the COOH terminus of factor Va heavy chain that regulates the rate and pathway for prothrombin activation.

Authors:  Michael A Bukys; Paul Y Kim; Michael E Nesheim; Michael Kalafatis
Journal:  J Biol Chem       Date:  2006-10-04       Impact factor: 5.157

6.  Defining the factor Xa-binding site on factor Va by site-directed glycosylation.

Authors:  Mårten Steen; Bruno O Villoutreix; Eva A Norstrøm; Tomio Yamazaki; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2002-10-15       Impact factor: 5.157

7.  The discovery of factor V: a tricky clotting factor.

Authors:  H Stormorken
Journal:  J Thromb Haemost       Date:  2003-02       Impact factor: 5.824

8.  The role of phospholipids and factor Va in the prothrombinase complex.

Authors:  J Rosing; G Tans; J W Govers-Riemslag; R F Zwaal; H C Hemker
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

9.  Structure of human phosphatidylcholine transfer protein in complex with its ligand.

Authors:  Steven L Roderick; Wayne W Chan; Diana S Agate; Laurence R Olsen; Matt W Vetting; K R Rajashankar; David E Cohen
Journal:  Nat Struct Biol       Date:  2002-07

Review 10.  Mechanisms of ligand binding.

Authors:  Enrico Di Cera
Journal:  Biophys Rev       Date:  2020-12
View more
  4 in total

1.  Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations.

Authors:  Luis Javier Serrano; Mariano Garcia-Arranz; Juan A De Pablo-Moreno; José Carlos Segovia; Rocío Olivera-Salazar; Damián Garcia-Olmo; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

2.  Cryo-EM structure of the prothrombin-prothrombinase complex.

Authors:  Eliza A Ruben; Brock Summers; Michael J Rau; James A J Fitzpatrick; Enrico Di Cera
Journal:  Blood       Date:  2022-06-16       Impact factor: 25.476

3.  First Insights into the Repertoire of Secretory Lectins in Rotifers.

Authors:  Marco Gerdol
Journal:  Mar Drugs       Date:  2022-02-09       Impact factor: 5.118

Review 4.  The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.

Authors:  Juan A De Pablo-Moreno; Luis Javier Serrano; Luis Revuelta; María José Sánchez; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.